| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| CRO服务(元) | 99,737,469.52 | 168,526,230.05 | 88,344,706.53 | 154,050,799.31 | 69,640,140.02 |
| 房屋租赁(元) | 14,137,201.74 | 26,380,914.64 | 13,696,680.31 | 15,442,203.39 | 1,639,028.44 |
| 基因(元) | 4,821,358.94 | 8,553,807.22 | 4,855,486.63 | 11,773,519.64 | 5,484,063.62 |
| 抗体(元) | 44,383,113.38 | 106,492,689.82 | 52,036,491.77 | 181,105,879.36 | 68,724,954.48 |
| 培养基(元) | 13,484,161.35 | 28,226,002.54 | 13,300,423.26 | 27,659,803.19 | 13,703,782.48 |
| 重组蛋白(元) | 146,143,315.15 | 273,114,403.87 | 132,757,298.11 | 255,555,958.16 | 133,186,079.04 |
| 其他(元) | 1,748,554.71 | 2,377,468.91 | 669,871.16 | 800,337.33 | - |
| 营业成本(元) | |||||
| CRO服务(元) | 47,652,837.66 | 88,340,000.88 | 45,404,360.94 | 46,800,977.61 | 28,709,840.99 |
| 房屋租赁(元) | 3,613,808.45 | 6,783,675.60 | 3,536,669.10 | 4,126,113.95 | 589,444.85 |
| 基因(元) | 174,299.69 | - | 601,934.63 | - | - |
| 抗体(元) | 4,029,013.13 | 11,979,477.01 | 7,103,848.53 | 20,501,636.44 | 7,638,875.75 |
| 培养基(元) | 5,811,065.44 | - | 5,193,857.28 | - | - |
| 重组蛋白(元) | 21,756,355.96 | 42,119,660.87 | 18,548,998.11 | 31,497,967.73 | 17,074,594.80 |
| 其他(元) | 1,310,333.97 | - | 593,074.32 | - | - |
| 毛利(元) | |||||
| CRO服务(元) | 52,084,631.86 | 80,186,229.17 | 42,940,345.59 | 107,249,821.70 | 40,930,299.03 |
| 房屋租赁(元) | 10,523,393.29 | 19,597,239.04 | 10,160,011.21 | 11,316,089.44 | 1,049,583.59 |
| 基因(元) | 4,647,059.25 | - | 4,253,552.00 | - | - |
| 抗体(元) | 40,354,100.25 | 94,513,212.81 | 44,932,643.24 | 160,604,242.92 | 61,086,078.73 |
| 培养基(元) | 7,673,095.91 | - | 8,106,565.98 | - | - |
| 重组蛋白(元) | 124,386,959.19 | 230,994,743.00 | 114,208,300.00 | 224,057,990.43 | 116,111,484.24 |
| 其他(元) | 438,220.74 | - | 76,796.84 | - | - |
| 毛利率(%) | |||||
| CRO服务(%) | 52.22 | 47.58 | 48.61 | 69.62 | 58.77 |
| 房屋租赁(%) | 74.44 | 74.29 | 74.18 | 73.28 | 64.04 |
| 基因(%) | 96.38 | - | 87.60 | - | - |
| 抗体(%) | 90.92 | 88.75 | 86.35 | 88.68 | 88.88 |
| 培养基(%) | 56.90 | - | 60.95 | - | - |
| 重组蛋白(%) | 85.11 | 84.58 | 86.03 | 87.67 | 87.18 |
| 其他(%) | 25.06 | - | 11.46 | - | - |
| 收入构成(%) | |||||
| CRO服务(%) | 30.74 | 27.46 | 28.90 | 23.83 | 23.82 |
| 房屋租赁(%) | 4.36 | 4.30 | 4.48 | 2.39 | 0.56 |
| 基因(%) | 1.49 | 1.39 | 1.59 | 1.82 | 1.88 |
| 抗体(%) | 13.68 | 17.35 | 17.02 | 28.02 | 23.51 |
| 培养基(%) | 4.16 | 4.60 | 4.35 | 4.28 | 4.69 |
| 重组蛋白(%) | 45.04 | 44.50 | 43.43 | 39.54 | 45.55 |
| 其他(%) | 0.54 | 0.39 | 0.22 | 0.12 | - |
| 毛利构成(%) | |||||
| CRO服务(%) | 21.69 | 18.85 | 19.11 | 21.31 | 18.67 |
| 房屋租赁(%) | 4.38 | 4.61 | 4.52 | 2.25 | 0.48 |
| 基因(%) | 1.94 | 0.00 | 1.89 | 0.00 | 0.00 |
| 抗体(%) | 16.81 | 22.22 | 20.00 | 31.91 | 27.87 |
| 培养基(%) | 3.20 | 0.00 | 3.61 | 0.00 | 0.00 |
| 重组蛋白(%) | 51.80 | 54.31 | 50.83 | 44.52 | 52.98 |
| 其他(%) | 0.18 | 0.00 | 0.03 | 0.00 | - |